Primary and secondary endpoints of the RECOURSE trial for which TAS-102 was approved at Annual Meeting GI 2016

Alan P. Venook, MD of University of California San Francisco discusses the primary and secondary endpoints of the RECOURSE trial for which TAS-102 was approved at ASCO GI 2016